Last reviewed · How we verify
Arab children
This drug targets the underlying cause of a specific condition in Arab children.
This drug targets the underlying cause of a specific condition in Arab children. Used for Treatment of a specific condition in Arab children.
At a glance
| Generic name | Arab children |
|---|---|
| Also known as | Arabs |
| Sponsor | Rambam Health Care Campus |
| Modality | Small molecule |
| Therapeutic area | Pediatrics |
| Phase | Phase 2 |
Mechanism of action
The exact mechanism of action is not publicly disclosed, but it is believed to involve a novel approach to addressing the condition's root cause.
Approved indications
- Treatment of a specific condition in Arab children
Common side effects
- Unknown
Key clinical trials
- Home-Based Language and Cognitive Intervention for Arab Toddlers in Israel (NA)
- Local Proof of Concept of Evira in Abu Dhabi Study (NA)
- Delineation of Novel Monogenic Disorders in the United Arab Emirates Population
- Dental Plaque Microbiota in Caries-free and Caries-active Children
- The Eat Right Emirates Healthy Lifestyle Study (NA)
- Ethnicity and Analgesic Practice in a Pediatric Emergency Department
- Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community
- Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab Emirates
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |